feed,title,long_url,short_url
BioRxiv,COVIDOUTCOME - Estimating COVID Severity Based on Mutation Signatures in the SARS-CoV-2 Genome,https://biorxiv.org/cgi/content/short/2021.04.01.438063v1?rss=1,https://j.mp/3cHXL0R
BioRxiv,Discovery and in-vitro evaluation of potent SARS-CoV-2 entry inhibitors,https://biorxiv.org/cgi/content/short/2021.04.02.438204v1?rss=1,https://j.mp/39DVfa2
BioRxiv,An immunoinformatics approach to study the epitopes contributed by Nsp13 of SARS-CoV-2,https://biorxiv.org/cgi/content/short/2021.04.02.438155v1?rss=1,https://j.mp/3cL0vus
BioRxiv,SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity,https://biorxiv.org/cgi/content/short/2021.04.02.438186v1?rss=1,https://j.mp/3dtUKAt
